Does Alnylam Pharmaceuticals (ALNY) Pay a Dividend? (2026)
Last updated July 2026
Short answer
Alnylam Pharmaceuticals (ALNY) pays a dividend with an approximate yield of None as of early 2026, typically quarterly. A dividend is a slice of profits returned to shareholders, and the yield is that payout divided by the share price, so it drifts as both change. Figures here are approximate; verify the current number with your broker.
Does Alnylam Pharmaceuticals (ALNY) pay a dividend?
Yes. Alnylam Pharmaceuticals distributes an approximate None yield (early 2026), usually quarterly. Alnylam reached profitability in 2025 after nearly $3 billion in net product revenue, and Q1 2026 delivered about $1.0 billion in net product revenue with roughly $206 million of net income. At a market cap near $42 billion against 2026 revenue guidance of roughly $5 billion, the stock carries a premium multiple that prices in continued rapid growth. It pays no dividend and reinvests cash into its RNAi pipeline.
How to think about ALNY's dividend
- Yield is a snapshot: None today, but it moves with price and payout.
- Total return vs income: dividends are one part of return; price change is usually the bigger part for a name like ALNY.
- Reinvest or take income: a DRIP compounds; taking the cash gives income now.
- For more yield: dedicated dividend stocks and ETFs target higher payouts. See the best dividend ETFs.
The bottom line on the ALNY dividend
Alnylam Pharmaceuticals (ALNY) pays an approximate None dividend, so it offers some income but is held mostly for total return, not yield. For the full picture see the ALNY guide. Walnut can show how ALNY fits your real portfolio. It is not an investment adviser.
Build a basket around ALNY with Walnut
Use Alnylam Pharmaceuticals as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Does Alnylam Pharmaceuticals (ALNY) pay a dividend?
+
Alnylam Pharmaceuticals has an approximate dividend yield of None (early 2026). Yields move with price and payout, so treat this as a recent snapshot and verify the current figure with your broker or ALNY's investor relations page.
What is ALNY's dividend yield?
+
Approximately None as of early 2026 (approximate, verify). Remember a higher yield is not automatically better: it can reflect a falling share price as much as a generous payout.
How often does ALNY pay its dividend?
+
US companies that pay dividends, like Alnylam Pharmaceuticals if it does, typically distribute them quarterly. Confirm the exact schedule and ex-dividend dates on ALNY's investor relations page before relying on the timing.
Can I reinvest ALNY dividends?
+
Yes. Most brokers offer automatic dividend reinvestment (a DRIP) so any ALNY dividend buys more shares automatically. It compounds over time but is still taxable in a taxable account.
Is ALNY a good dividend stock?
+
Walnut is informational, not investment advice. With an approximate None yield, ALNY is more of a growth or total-return name than a high-yield one. Dedicated dividend stocks and ETFs target higher, steadier yield; match the choice to whether you want income now or growth.
Does ALNY pay a dividend?
+
No, Alnylam does not pay a dividend. Like most growth-stage biotechs, it reinvests its cash into research, clinical trials, and commercial expansion of its RNAi pipeline. Investors in ALNY are relying entirely on share-price appreciation rather than income. That reflects a company still prioritizing growth over returning capital.
Walnut is informational, not investment advice. Dividend figures are approximate and dated; verify current yield, schedule, and policy with ALNY's investor relations page or your broker.